Detalles de la búsqueda
1.
High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss.
Eur Respir J
; 57(1)2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32703777
2.
Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort study.
Int Health
; 15(3): 258-264, 2023 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35420123
3.
High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin.
Int J Infect Dis
; 133: 78-81, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37150352
4.
Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation.
Trials
; 23(1): 1011, 2022 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36514153
5.
Programmatic Implementation of Contact Investigation in Eight African Countries.
Trop Med Infect Dis
; 8(1)2022 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36668936
6.
Priority Activities in Child and Adolescent Tuberculosis to Close the Policy-Practice Gap in Low- and Middle-Income Countries.
Pathogens
; 11(2)2022 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35215139
7.
Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements.
Respir Med
; 161: 105844, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32056722
Resultados
1 -
7
de 7
1
Próxima >
>>